CARREGA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.477
EU - Europa 1.117
AS - Asia 912
SA - Sud America 344
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.879
Nazione #
US - Stati Uniti d'America 1.451
SG - Singapore 367
BR - Brasile 305
CN - Cina 274
IT - Italia 250
IE - Irlanda 235
SE - Svezia 222
PL - Polonia 157
HK - Hong Kong 113
VN - Vietnam 75
DE - Germania 45
GB - Regno Unito 35
RU - Federazione Russa 30
UA - Ucraina 28
FI - Finlandia 27
FR - Francia 22
BE - Belgio 21
AR - Argentina 17
AT - Austria 16
IN - India 15
CA - Canada 11
ZA - Sudafrica 11
ID - Indonesia 10
BD - Bangladesh 9
MX - Messico 9
EC - Ecuador 7
IQ - Iraq 7
MA - Marocco 7
TR - Turchia 7
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
ES - Italia 5
NL - Olanda 5
PH - Filippine 5
PK - Pakistan 5
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
JP - Giappone 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.879
Città #
Dublin 235
Ashburn 205
Chandler 188
Singapore 167
Dallas 158
Warsaw 157
Nyköping 153
Messina 144
Beijing 116
Hong Kong 112
Jacksonville 74
Ann Arbor 65
The Dalles 59
Los Angeles 39
Princeton 37
Medford 34
Des Moines 27
Dearborn 26
Ho Chi Minh City 26
Cambridge 25
Brussels 21
São Paulo 21
Boardman 20
Buffalo 16
Munich 16
New York 15
Redondo Beach 15
Dong Ket 14
Wilmington 14
Woodbridge 14
Shenyang 13
Vienna 13
Nanjing 12
Tianjin 12
Jinan 11
Moscow 11
San Mateo 11
Belo Horizonte 10
Zhengzhou 10
Johannesburg 9
Rio de Janeiro 9
Seattle 9
Stockholm 9
Changsha 8
Hanoi 8
Jakarta 8
Milan 8
Santa Clara 8
Hebei 7
Ningbo 7
São Bernardo do Campo 6
Taizhou 6
Tashkent 6
West Jordan 6
Atlanta 5
Brno 5
Brooklyn 5
Chennai 5
Genova 5
Haikou 5
London 5
Montreal 5
Nova Iguaçu 5
Rome 5
Aci Bonaccorsi 4
Boston 4
Brasília 4
Campinas 4
Canoas 4
Catania 4
Caxias do Sul 4
Curitiba 4
Düsseldorf 4
Fuzhou 4
General Mamerto Natividad 4
Genoa 4
Guangzhou 4
Hangzhou 4
Manchester 4
Nanchang 4
Phoenix 4
Porto Alegre 4
Pune 4
Salvador 4
Shanghai 4
Tappahannock 4
Amsterdam 3
Baghdad 3
Baku 3
Campo Grande 3
Chicago 3
Duque de Caxias 3
Fortaleza 3
Goiânia 3
Houston 3
Hải Dương 3
Iporá 3
Juazeiro do Norte 3
Lauterbourg 3
Mexico City 3
Totale 2.610
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 191
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 173
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. 143
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 136
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 123
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 116
Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells 115
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. 112
Cross-dressing: an alternative mechanism for antigen presentation 111
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 108
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 108
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 105
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 103
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells 103
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN-α Production 99
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 99
The Yin and Yang of Innate Lymphoid Cells in Cancer 98
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 98
Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma 98
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 95
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 95
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 94
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 92
Human NK cells and NK receptors. 91
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 88
Characterization of human afferent lymph dendritic cells from seroma fluids. 87
Natural Killer cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on dendritic cells 86
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 85
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies 85
ILC in chronic inflammation, cancer and targeting with biologicals 83
Identification of Natural Killer Cells in Tissues and Their Isolation 72
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 68
Principles of NK cell/DC crosstalk: The importance of cell dialogue for a protective immune response 63
Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer 63
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-alpha production. 61
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 57
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses 56
BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features 56
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response 54
Natural killer cells infiltrating human non small-cell lung cancer are enriched inCD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. 53
Natural killer cell distribution and trafficking in human tissues. 50
null 44
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 37
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 35
Murine models to study human NK cells in human solid tumors 25
Totale 4.014
Categoria #
all - tutte 15.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 28 34 22 32 65 50 30
2021/2022264 9 31 3 16 13 8 29 17 5 16 34 83
2022/2023728 67 68 39 61 49 72 8 52 273 2 15 22
2023/2024173 13 28 29 12 14 23 1 9 6 4 4 30
2024/2025913 23 4 14 51 39 29 25 233 183 62 102 148
2025/20261.063 179 180 186 207 278 33 0 0 0 0 0 0
Totale 4.014